Insights

Innovative HIV Treatment ImmunoScience's flagship product, Contre Vir™, represents a groundbreaking therapeutic vaccine for HIV that has demonstrated high success in pre-clinical and pilot clinical studies, positioning the company as a pioneer in HIV cure research.

Global Clinical Expansion The company is preparing to initiate Phase I clinical trials across multiple countries including the US, Belgium, Ghana, and Uganda, indicating potential opportunities to collaborate on international research and licensing.

Patent Portfolio Strength With several patents secured worldwide for Contre Vir™, ImmunoScience holds a competitive advantage, which could be leveraged for licensing deals or strategic partnerships in the biotech and pharmaceutical sectors.

Growing Market Interest The high level of interest in final-stage studies suggests a significant market demand for innovative HIV treatments, presenting opportunities to engage with healthcare providers, governments, and NGOs focused on infectious disease eradication.

Strategic Funding Position While revenue is currently estimated between 1 to 10 million dollars, the company's active development pipeline and upcoming clinical trials present strong potential for attracting investments and expanding sales channels in the biotech space.

ImmunoScience, Inc. Email Formats	Example	Percentage
First.Last@immunoscience.com	John.Doe@immunoscience.com	50%
First.Last@immunoscience.com	John.Doe@immunoscience.com	50%

ImmunoScience, Inc. Email Formats

Example

Percentage

First.Last@immunoscience.com

John.Doe@immunoscience.com

50%

First.Last@immunoscience.com

John.Doe@immunoscience.com

50%

Frequently Asked Questions

Where is ImmunoScience, Inc.'s headquarters located?

ImmunoScience, Inc.'s main headquarters is located at United States. The company has employees across 2 continents, including North AmericaAsia.

What is ImmunoScience, Inc.'s phone number?

You can contact ImmunoScience, Inc.'s main corporate office by phone at

+1-925-460-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ImmunoScience, Inc.'s official website and social media links?

ImmunoScience, Inc.'s official website is immunoscience.com and has social profiles on LinkedIn.

How much revenue does ImmunoScience, Inc. generate?

As of December 2025, ImmunoScience, Inc.'s annual revenue is estimated to be $6M.

What is ImmunoScience, Inc.'s SIC code NAICS code?

ImmunoScience, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ImmunoScience, Inc. have currently?

As of December 2025, ImmunoScience, Inc. has approximately 11 employees across 2 continents, including North AmericaAsia. Key team members include VP Marketing/Business Development: A. A.President: A. S.Vice President, Planning And Investor Communications: R. N.. Explore ImmunoScience, Inc.'s employee directory with LeadIQ.

What industry does ImmunoScience, Inc. belong to?

ImmunoScience, Inc. operates in the Biotechnology Research industry.

What technology does ImmunoScience, Inc. use?

ImmunoScience, Inc.'s tech stack includes DreamWeaverjQueryApache HTTP ServerNginxApache.

What is ImmunoScience, Inc.'s email format?

ImmunoScience, Inc.'s email format typically follows the pattern of First.Last@immunoscience.com. Find more ImmunoScience, Inc. email formats with LeadIQ.

ImmunoScience, Inc.

Q: What is ImmunoScience, Inc.'s official website and social media links?

ImmunoScience, Inc.'s official website is immunoscience.com. ImmunoScience, Inc. has social profiles on LinkedIn.

Q: How many employees does ImmunoScience, Inc. have currently?

ImmunoScience, Inc. has approximately 11 employees.

Q: What technology does ImmunoScience, Inc. use?

ImmunoScience, Inc.'s tech stack includes Apache HTTP Server, DreamWeaver, jQuery, Nginx, Apache.

Q: What is ImmunoScience, Inc.'s NAICS code?

ImmunoScience, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchUnited States11-50 Employees

ImmunoScience, Inc. is a biotechnology research and development company specializing in the diagnosis and treatment of HIV. ImmunoScience's flagship product is Contre Vir™, a recombinant, live, attenuated therapeutic vaccine for the treatment and potential cure of AIDS and the HIV infection. Contre Vir™ has shown a very high level of success in pre-clinical studies and pilot clinical trials. Further studies are in final planning stages in several countries where interest is extremely high. ImmunoScience has several patents for Contre Vir™ across the globe and is expected to start Phase I clinical trials for Contre Vir™ in the very near future. The preliminary work for these trials is already underway in the United States, Belgium, Ghana and Uganda. ImmunoScience considers this invention to be a ground-breaking step forward in the fight against AIDS and HIV.

Insights

Similar companies to ImmunoScience, Inc.

Bio-Rad Laboratories

Roche

Danaher Corporation

abcam

Thermo Fisher Scientific

Agilent Technologies

Siemens Healthineers